alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › states

states

3 studies tagged states, dated 2019-04-17 to 2023-06-08. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Blood-based biomarkers for Alzheimer's disease: Current state and future use in a transformed global healthcare landscape 2023-06-08
  2. Nanoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer's disease - A cross-validation study 2020-03-25
  3. Comparative analyses of plasma amyloid-β levels in heterogeneous and monomerized states by interdigitated microelectrode sensor system 2019-04-17

Studies

3 studies carry this tag.

Date range

2019 to 2023

Top journals

  • Nanomedicine : nanotechnology, biology, and medicine 1
  • Neuron 1
  • Science advances 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Blood-based biomarkers for Alzheimer's disease: Current state and future use in a transformed global healthcare landscape

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Neuron 2023-06-08 Tau biomarkers

    Timely detection of the pathophysiological changes and cognitive impairment caused by Alzheimer's disease (AD) is increasingly pressing because of the advent of biomarker-guided targeted therapies that may be most effective when provided early in the disease.

  2. Nanoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer's disease - A cross-validation study

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Nanomedicine : nanotechnology, biology, and medicine 2020-03-25 Biomarkers

    Blood-based biomarker assays of plasma β-amyloid (Aβ) and tau have the advantages of cost-effective and less invasive for the diagnosis of Alzheimer's disease (AD).

  3. Comparative analyses of plasma amyloid-β levels in heterogeneous and monomerized states by interdigitated microelectrode sensor system

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Science advances 2019-04-17 Biomarkers

    Detection of amyloid-β (Aβ) aggregates contributes to the diagnosis of Alzheimer disease (AD).

All topic tags with their study counts